During the corresponding time, Zeo Scientifix Inc recorded a revenue increase by 124.63 % year on year, sequentially revenue grew by 78.49 %. While revenue at the Zeo Scientifix Inc 's corporate clients
Zeo Scientifix Inc's Comment on Sales, Marketing and Customers
The Company has obtained Investigational New Drug (IND) and emergency IND (eIND) approvals from the FDA, including Institutional Review Board (IRB) approvals, authorizing the commencement of clinical trials or treatments using Zofin™ and related protocols. It is pursuing the completion of approved clinical studies and seeking approval for additional studies targeting other indications. The Company is expanding international sales and developing new product offerings or designations to address risks related to FDA regulations. On February 4, 2025, the Company entered into a Binding Memorandum of Understanding with BioXtek, LLC for joint development, manufacturing, marketing, and funding; however, definitive agreements have not been executed.
Zeo Scientifix Inc’s Comment on Sales, Marketing and Customers
The Company has obtained Investigational New Drug (IND) and emergency IND (eIND) approvals from the FDA, including Institutional Review Board (IRB) approvals, authorizing the commencement of clinical trials or treatments using Zofin™ and related protocols. It is pursuing the completion of approved clinical studies and seeking approval for additional studies targeting other indications. The Company is expanding international sales and developing new product offerings or designations to address risks related to FDA regulations. On February 4, 2025, the Company entered into a Binding Memorandum of Understanding with BioXtek, LLC for joint development, manufacturing, marketing, and funding; however, definitive agreements have not been executed.
Sources:
Zeo Scientifix Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Zeo Scientifix Inc’s corporate clients.
For your research, we’ve provided 9 tables on Zeo Scientifix Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
